Evidence map›Paper›PMID 38445382›Full record

Trial reportPsychological medicine2024

The effects of intranasal oxytocin on the efficacy of psychotherapy for major depressive disorder: a pilot randomized controlled trial.

Mark A Ellenbogen, Christopher Cardoso, Lisa Serravalle, Kiran Vadaga, Ridha Joober

Open access · hybridAbstract readClinical Trial, Phase IIRandomized Controlled Trial
In one paragraph

Trial report in Psychological medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
9.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Neuropeptidergic systems in psychiatric disorders.Frontiers in endocrinology · 2025
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Mark A EllenbogenCentre for Research in Human Development, Department of Psychology, Concordia University, Montréal, Canada.ORCID 0000-0001-8928-5492
Christopher CardosoCentre for Research in Human Development, Department of Psychology, Concordia University, Montréal, Canada.
Lisa SerravalleCentre for Research in Human Development, Department of Psychology, Concordia University, Montréal, Canada.
Kiran VadagaCentre for Research in Human Development, Department of Psychology, Concordia University, Montréal, Canada.
Ridha JooberThe Douglas Research Centre, Department of Psychiatry, McGill University, Montréal, Canada.
Concordia University · CAMcGill University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough both pharmacotherapy and psychological treatments are considered to be efficacious in the treatment of major depressive disorder (MDD), one third of patients do not respond to treatment and many experience residual symptoms post-treatment. In this double-blind placebo-controlled randomized control trial (RCT), we assessed whether intranasal oxytocin (OT) augments the therapeutic efficacy of psychotherapy for MDD and improves the therapeutic alliance.

methodsTwenty-three volunteers (12 female) with MDD underwent 16 sessions of interpersonal therapy. Prior to each session, volunteers self-administered 24 International Units of intranasal OT (

resultsMultilevel modeling found a significant effect of OT on the negative slope of depressive symptoms over time (

conclusionIn this pilot study, the administration of intranasal OT, relative to placebo, improved the therapeutic alliance at the beginning of therapy and therapeutic efficacy of psychotherapy in persons with MDD. Future RCTs should attempt to replicate these findings in larger samples with different therapeutic modalities (

Indexed as

Administration, IntranasalMajor Depressive DisorderOxytocinAdultCombined Modality TherapyDouble-Blind MethodFemaleHumansInterpersonal PsychotherapyMaleMiddle AgedOutcome Assessment, Health CarePilot ProjectsPsychotherapyTreatment OutcomeYoung AdultOxytocinintranasal oxytocinmajor depressive disorderpsychotherapytherapeutic alliance

Identifiers

PMID38445382
PMCPMC11413360
OpenAlexW4392510028

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.